does pfizer have a glp 1 drug Is on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market? Pfizer moves forward with once-daily
Description
10.1016/S2666-7568(23)00211-8 Lancet Healthy Longev
Front Immunol 14:1148209
In contrast, single injection of Tregs or IL-10 overexpressing engineered T cells promoted gene expression of chemokines/cytokines in microglia (Ccl2, Ccl7, and Cxcl10), regulated the chemotactic behavior of microglia and neural stem cells, promoted angiogenesis, and was speculated to contribute to the repair of ischemic injury (95)
Strongest Current Evidence CagriSema REDEFINE 1 and REDEFINE 2 are completed phase 3 trials published in NEJM with over 4,600 participants
Conclusion and future directions The evidence from both randomized controlled trials and real-world data suggests that GLP-1 receptor agonists, such as Ozempic, may have a role in reducing the incidence of dementia in individuals with type 2 diabetes
Ricca, V., Mannucci, E., Moretti, S., Di Bernardo, M., Zucchi, T., Cabras, P
